Skip to main content

Natesto News

Testosterone Tied to Incidence, Progression of Metabolic Syndrome

THURSDAY, July 11, 2024 – Testosterone is associated with a greater risk for development and progression of metabolic syndrome, particularly in transmasculine individuals, according to a study...

Male Birth Control Gel Shows Promise in Trial

MONDAY, June 3, 2024 – A new hormonal gel could one day be a potential form of birth control for men, researchers reported Sunday. “The development of a safe, highly effective and reliably r...

All-Cause Mortality Risk Up for Men With Low Testosterone

MONDAY, May 13, 2024 – The risk for all-cause mortality is increased for men with low testosterone, high luteinizing hormone, or very low estradiol, according to a review published online May 14 in...

FDA Medwatch Alert: FDA Alerts Customers to Voluntary Recall of Compounded Drugs Due to Sterility Issues by Drug Depot, LLC, dba APS Pharmacy

April 26, 2022 --FDA is alerting patients, health care professionals, veterinarians, and animal owners/caretakers about a voluntary recall by Drug Depot, LLC, doing business as APS Pharmacy, of...

FDA Medwatch Alert: Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement - Risks Associated With Abuse and Dependence

ISSUE: FDA approved class-wide labeling changes for all prescription testosterone products, adding a new Warning and updating the Abuse and Dependence section to include new safety information from...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Hypogonadism - Male

Natesto patient information at Drugs.com